Information Provided By:
Fly News Breaks for January 7, 2020
Jan 7, 2020 | 16:35 EDT
SunTrust analyst Kaila Krum initiated coverage of BioTelemetry with a Buy rating and $58 price target. The analyst estimates the company's mobile cardiac outpatient telemetry business has delivered "robust" high-single digit growth historically, and that there is still room to take share from traditional ECG monitors in patients with more infrequent symptoms.
News For BEAT From the Last 2 Days
There are no results for your query BEAT